A Multicenter Exploratory Clinical Study of Iruplaltinib Combined With Pemetrexed as Neoadjuvant Therapy for Resectable ALK-Positive Non-Squamous Non-Small Cell Lung Cancer
A Multicenter Exploratory Clinical Study of Iruplaltinib Combined With Pemetrexed as Neoadjuvant Therapy for Resectable ALK-Positive Non-Squamous Non-Small Cell Lung Cancer
Not yet recruiting · NCT07771764 · Registry updated 2026-08-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Multicenter Exploratory Clinical Study of Iruplaltinib Combined With Pemetrexed as Neoadjuvant Therapy for Resectable ALK-Positive Non-Squamous Non-Small Cell Lung Cancer | ALK-positive Non Small Cell Lung Cancer | Not yet recruiting | Phase 2 | 2026-08-18 | NCT07771764 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| First Affiliated Hospital of Fujian Medical University | 88 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fuzhou Pulmonary Hospital | Fuzhou | China | 1 |
| Fuzhou University Affiliated Provincial Hospital | Fuzhou | China | 7 |
| The First Affiliated Hospital of Fujian Medical University | Fuzhou | China | 21 |
| The Second Attached Hospital of Fujian Medical University | Quanzhou | China | 1 |
| The Second Hospital of Longyan | Longyan | China | 1 |
| Xiamen Medical College Affiliated Second Hospital | Xiamen | China | 1 |
| Zhangzhou Hospital | Zhangzhou | China | 2 |